Vaccine for prevention of lyme borreliosis

0532786 - FZÚ 2021 RIV eng P - Patentový dokument
Bittner, L. - Kratochvílová, Irena - Křupka, M. - Ledvina, Miroslav - Mašek, J. - Nepeřený, J. - Raška, M. - Turánek, J. - Vrzal, V. - Weigl, E.
Vaccine for prevention of lyme borreliosis.
2020. Vlastník: Univerzita Palackého v Olomouci - Bioveta, a.s. - Fyzikální ústav AV ČR, v. v. i. - Ústav organické chemie a biochemie AV ČR, v. v. i. - Výzkumný ústav veterinárního lékařství ,v. v. i. Datum udělení patentu: 09.09.2020. Číslo patentu: EP3139951
Grant CEP: GA ČR(CZ) GA15-05095S
Institucionální podpora: RVO:68378271 ; RVO:61388963
Klíčová slova: biotechnology * plant genetics * vaccines
Obor OECD: Immunology; Organic chemistry (UOCHB-X)
https://worldwide.espacenet.com/patent/search/family/053373225/publication/EP3139951A1?q=EP3139951

NOVELTY - Vaccine for treating and preventing Lyme borreliosis for human and veterinary use, comprises: (a) at least one chimeric polyepitope recombinant antigen containing 2-6, preferably 6 immunodominant regions and a terminal region selected from oriented sequences of immunodominant regions of outer surface protein C (Osp) C antigens, (b) at least one chimeric polyepitope recombinant antigen containing 2-7, preferably 7, immunodominant regions and a terminal region selected from oriented sequences of immunodominant regions of OspA antigens, and (c) at least one adjuvant and/or ferritin II. USE - The vaccine is useful for treating and preventing Lyme borreliosis for human and veterinary use or in veterinary and/or human medicine (claimed).
Trvalý link: http://hdl.handle.net/11104/0311198